BRIACELL THERAPEUTICS CORP. (BCTXL) Operating cash flow 2021–2026
BRIACELL THERAPEUTICS CORP. (BCTXL) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$28.7MFY2026 · since FY2021: -$7.8M → -$28.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | -$28.7M | -1.7% |
| FY2025 | -$28.2M | -16.8% |
| FY2024 | -$24.1M | -1.6% |
| FY2023 | -$23.7M | -90.2% |
| FY2022 | -$12.5M | -61.1% |
| FY2021 | -$7.8M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More BCTXL financial trends
BCTXL RevenueBCTXL Net incomeBCTXL Net marginBCTXL Gross profitBCTXL Gross marginBCTXL Operating incomeBCTXL Operating marginBCTXL Free cash flowBCTXL Capital expendituresBCTXL Return on equityBCTXL Stock buybacksBCTXL Dividends paidBCTXL Total assetsBCTXL Total liabilitiesBCTXL Shareholders’ equityBCTXL overview →